HP analyst estimates
Helmerich & Payne (HP) analyst ratings, the average price target and its range, and every firm's latest call.
HP analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 12, 2026 | UBS | Helmerich & Payne price target raised to $50 from $49 at UBS | $50.00 |
| Oct 5, 2026 | Susquehanna | Helmerich & Payne price target raised to $50 from $44 at Susquehanna | $50.00 |
| Oct 2, 2026 | UBS | Helmerich & Payne initiated with a Buy at UBS | $49.00 |
| Sep 10, 2026 | RBC Capital | Helmerich & Payne price target raised to $49 from $44 at RBC Capital | $49.00 |
| Aug 20, 2026 | Morgan Stanley | Helmerich & Payne price target raised to $41 from $36 at Morgan Stanley | $41.00 |
| Aug 10, 2026 | Barclays | Helmerich & Payne price target raised to $50 from $47 at Barclays | $50.00 |
| Jul 15, 2026 | Morgan Stanley | Helmerich & Payne price target lowered to $36 from $39 at Morgan Stanley | $36.00 |
| Jun 3, 2026 | Goldman Sachs | Helmerich & Payne price target raised to $41 from $35 at Goldman Sachs | $41.00 |
| May 18, 2026 | Piper Sandler | Helmerich & Payne price target raised to $43 from $41 at Piper Sandler | $43.00 |
| May 14, 2026 | Morgan Stanley | Helmerich & Payne price target raised to $39 from $35 at Morgan Stanley | $39.00 |
| May 8, 2026 | Susquehanna | Helmerich & Payne price target raised to $43 from $42 at Susquehanna | $43.00 |
| Apr 15, 2026 | Piper Sandler | Helmerich & Payne price target raised to $41 from $40 at Piper Sandler | $41.00 |
| Apr 15, 2026 | Morgan Stanley | Helmerich & Payne price target raised to $35 from $30 at Morgan Stanley | $35.00 |
| Feb 10, 2026 | Barclays | Helmerich & Payne price target raised to $39 from $36 at Barclays | $39.00 |
| Feb 9, 2026 | Piper Sandler | Helmerich & Payne price target raised to $40 from $35 at Piper Sandler | $40.00 |
- 11 firms rate HP: 5 buy, 5 hold, 1 sell.
- The average price target is $46.29 from 7 analysts, from $41.00 to $50.00.
Updated 2026-11-02 23:10 UTC